Getinge (OTCMKTS:GNGBY) Shares Cross Below 50-Day Moving Average - Time to Sell?

Key Points

• Shares fell below their 50-day moving average, trading as low as $18.99 on Friday versus a 50-day MA of $22.09 and a 200-day MA of $22.49, a potential bearish technical signal.
• Recent results showed quarterly EPS of $0.47 on $1.08 billion in revenue; the company has a market cap of $5.17 billion, a PE of 22.08, ROE of 10.6% and modest leverage (debt/equity 0.27).
• Getinge is a global medical-technology firm focused on critical care, surgical workflows and infection control, with products including sterilization systems, ventilation equipment, heart-lung machines and ECMO devices.

Shares of Getinge (OTCMKTS:GNGBY - Get Free Report) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $22.09 and traded as low as $18.99. Getinge shares last traded at $18.99, with a volume of 5,073 shares changing hands.

Getinge Stock Performance

The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.86 and a current ratio of 1.32. The company has a market cap of $5.17 billion, a PE ratio of 22.08 and a beta of 1.08. The business's 50-day moving average is $22.09 and its 200 day moving average is $22.49.

Getinge (OTCMKTS:GNGBY - Get Free Report) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $0.47 earnings per share (EPS) for the quarter. The firm had revenue of $1.08 billion for the quarter. Getinge had a return on equity of 10.60% and a net margin of 6.54%.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company's offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge's solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company's product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.